Aging Impairs the ability of conventional dendritic cells to cross-prime CD8+ T cells upon stimulation with a TLR7 Ligand

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Zacca, Estefanía R ^a   Crespo, María I ^a   Acland, Rachel P ^a   Roselli, Emiliano ^a   Núñez, Nicolas G ^a   Maccioni, Mariana ^a   Maletto, Belkys A ^a   Pistoresi Palencia, María C ^a   Morón, Gabriel ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; OVALBUMIN; SINGLE STRANDED RNA; TOLL LIKE RECEPTOR 7; ANTIGEN; MEMBRANE PROTEIN; POLYURIDYLIC ACID; TLR7 PROTEIN, MOUSE;

AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; WESTERN BLOTTING; ANIMAL; CELLULAR IMMUNITY; CROSS PRESENTATION; DRUG EFFECTS; ENZYMOLOGY; IMMUNOLOGY;

AGING; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; CROSS-PRIMING; DENDRITIC CELLS; FEMALE; IMMUNITY, CELLULAR; MEMBRANE GLYCOPROTEINS; MICE; POLY U; TOLL-LIKE RECEPTOR 7;

EID: 84949495879     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140672     Document Type: Article

References (58)

1. Miller RA (1996) The aging immune system: primer and prospectus. Science 273: 70-74.
2. Linton PJ, Dorshkind K (2004) Age-related changes in lymphocyte development and function. Nat Immunol 5: 133-139.
3. Cambier J (2005) Immunosenescence: a problem of lymphopoiesis, homeostasis, microenvironment, and signaling. Immunol Rev 205: 5-6.
4. Kovacs EJ, Palmer JL, Fortin CF, Fulop T Jr., Goldstein DR, et al. (2009) Aging and innate immunity in the mouse: impact of intrinsic and extrinsic factors. Trends Immunol 30: 319-324. doi: 10.1016/j.it. 2009.03.012
5. Wong CP, Magnusson KR, Ho E (2010) Aging is associated with altered dendritic cells subset distribution and impaired proinflammatory cytokine production. Exp Gerontol 45: 163-169. doi: 10.1016/j. exger.2009.11.005
6. Agrawal A, Gupta S (2011) Impact of aging on dendritic cell functions in humans. Ageing Res Rev 10: 336-345. doi: 10.1016/j.arr.2010.06.004
7. Maletto B, Moron G, Pistoresi-Palencia MC (2010) Innate Immune System Modulation During Aging: Contributions of Macrophages and Dendritic Cells. Current Immunology Reviews 6: 329-338.
8. Jing Y, Shaheen E, Drake RR, Chen N, Gravenstein S, et al. (2009) Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood. Hum Immunol 70: 777-784. doi: 10.1016/j.humimm.2009.07.005
9. Moron G, Maletto B, Ropolo A, Pistoresi-Palencia MC (1998) Effect of aging on experimental autoimmune prostatitis: differential kinetics of development. Clin Immunol Immunopathol 87: 256-265.
10. Haynes L, Maue AC (2009) Effects of aging on T cell function. Curr Opin Immunol 21: 414-417. doi: 10.1016/j.coi.2009.05.009
11. Lopez-Bravo M, Ardavin C (2008) In vivo induction of immune responses to pathogens by conventional dendritic cells. Immunity 29: 343-351. doi: 10.1016/j.immuni.2008.08.008
12. Heath WR, Belz GT, Behrens GM, Smith CM, Forehan SP, et al. (2004) Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 199: 9-26
13. Guermonprez P, Amigorena S (2005) Pathways for antigen cross presentation. Springer Semin Immunopathol 26: 257-271.
14. Kurts C, Robinson BW, Knolle PA (2010) Cross-priming in health and disease. Nat Rev Immunol 10: 403-414. doi: 10.1038/nri2780
15. Li G, Smithey MJ, Rudd BD, Nikolich-Zugich J (2012) Age-Associated alterations in CD8alpha+ dendritic cells impair CD8 T-cell expansion in response to an intracellular bacterium. Aging Cell 11: 968-977. doi: 10.1111/j.1474-9726.2012.00867.x
16. Tan SY, Cavanagh LL, d'Advigor W, Shackel N, Fazekas de St Groth B, et al. (2012) Phenotype and functions of conventional dendritic cells are not compromised in aged mice. Immunol Cell Biol 90: 722-732. doi: 10.1038/icb.2011.104
17. Wong C, Goldstein DR (2013) Impact of aging on antigen presentation cell function of dendritic cells. Curr Opin Immunol 25: 535-541. doi: 10.1016/j.coi.2013.05.016
18. Crespo MI, Zacca ER, Nunez NG, Ranocchia RP, Maccioni M, et al. (2013) TLR7 Triggering with Polyuridylic Acid Promotes Cross-Presentation in CD8alpha+ Conventional Dendritic Cells by Enhancing Antigen Preservation and MHC Class I Antigen Permanence on the Dendritic Cell Surface. J Immunol 190: 948-960. doi: 10.4049/jimmunol.1102725
19. Kapsenberg ML (2003) Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 3: 984-993.
20. Reis e Sousa C (2006) Dendritic cells in a mature age. Nat Rev Immunol 6: 476-483.
21. Curtsinger JM, Johnson CM, Mescher MF (2003) CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J Immunol 171: 5165-5171.
22. Villadangos JA, Schnorrer P (2007) Intrinsic and cooperative antigen-presenting functions of dendriticcell subsets in vivo. Nat Rev Immunol 7: 543-555.
23. Colonna M, Trinchieri G, Liu YJ (2004) Plasmacytoid dendritic cells in immunity. Nat Immunol 5: 1219-1226.
24. Joffre OP, Segura E, Savina A, Amigorena S (2012) Cross-presentation by dendritic cells. Nat Rev Immunol 12: 557-569. doi: 10.1038/nri3254
25. Pooley JL, Heath WR, Shortman K (2001) Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8-dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J Immunol 166: 5327-5330.
26. Schulz O, Reis e Sousa C (2002) Cross-presentation of cell-Associated antigens by CD8alpha+ dendritic cells is attributable to their ability to internalize dead cells. Immunology 107: 183-189. PMID: 12383197
27. den Haan JM, Lehar SM, Bevan MJ (2000) CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med 192: 1685-1696.
28. van Dommelen SL, Rizzitelli A, Chidgey A, Boyd R, Shortman K, et al. (2010) Regeneration of dendritic cells in aged mice. Cell Mol Immunol 7: 108-115. doi: 10.1038/cmi.2009.114
29. Brossart P, Bevan MJ (1997) Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood 90: 1594-1599.
30. Steinman RM, Hawiger D, Nussenzweig MC (2003) Tolerogenic dendritic cells. Annu Rev Immunol 21: 685-711.
31. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, et al. (2007) Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 128: 92-105.
32. Watts C, Zaru R, Prescott AR, Wallin RP, West MA (2007) Proximal effects of Toll-like receptor activation in dendritic cells. Curr Opin Immunol 19: 73-78.
33. Kanno A, Tanimura N, Ishizaki M, Ohko K, Motoi Y, et al. (2015) Targeting cell surface TLR7 for therapeutic intervention in autoimmune diseases. Nat Commun 6: 6119. doi: 10.1038/ncomms7119 PMID: 25648980
34. Larange A, Antonios D, Pallardy M, Kerdine-Romer S (2009) TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation. J Leukoc Biol 85: 673-683. doi: 10.1189/jlb. 0808504
35. Tilstra JS, Robinson AR, Wang J, Gregg SQ, Clauson CL, et al. (2012) NF-kappaB inhibition delays DNA damage-induced senescence and aging in mice. J Clin Invest 122: 2601-2612. doi: 10.1172/JCI45785
36. Grolleau-Julius A, Harning EK, Abernathy LM, Yung RL (2008) Impaired dendritic cell function in aging leads to defective antitumor immunity. Cancer Res 68: 6341-6349. doi: 10.1158/0008-5472.CAN-07-5769
37. Pereira LF, de Souza AP, Borges TJ, Bonorino C (2011) Impaired in vivo CD4+ T cell expansion and differentiation in aged mice is not solely due to T cell defects: decreased stimulation by aged dendritic cells. Mech Ageing Dev 132: 187-194. doi: 10.1016/j.mad.2011.03.005
38. Grolleau-Julius A, Garg MR, Mo R, Stoolman LL, Yung RL (2006) Effect of aging on bone marrowderived murine CD11c+CD4-CD8alpha-dendritic cell function. J Gerontol A Biol Sci Med Sci 61: 1039-1047.
39. Shen H, Tesar BM, Du W, Goldstein DR (2009) Aging impairs recipient T cell intrinsic and extrinsic factors in response to transplantation. PLoS One 4: e4097. doi: 10.1371/journal.pone.0004097 PMID: 19119314
40. Tesar BM, Walker WE, Unternaehrer J, Joshi NS, Chandele A, et al. (2006) Murine [corrected] myeloid dendritic cell-dependent toll-like receptor immunity is preserved with aging. Aging Cell 5: 473-486. PMID: 17129212
41. Ordemann R, Hutchinson R, Friedman J, Burakoff SJ, Reddy P, et al. (2002) Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease. J Clin Invest 109: 1249-1256.
42. Hwang JS, Hwang JS, Chang I, Kim S (2007) Age-Associated decrease in proteasome content and activities in human dermal fibroblasts: restoration of normal level of proteasome subunits reduces aging markers in fibroblasts from elderly persons. J Gerontol A Biol Sci Med Sci 62: 490-499. PMID: 17522352
43. Low P (2011) The role of ubiquitin-proteasome system in ageing. Gen Comp Endocrinol 172: 39-43. doi: 10.1016/j.ygcen.2011.02.005
44. Shortman K, Heath WR (2010) The CD8+ dendritic cell subset. Immunol Rev 234: 18-31. doi: 10. 1111/j.0105-2896.2009.00870.x
45. Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K, et al. (2008) Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-Aging. Ageing Res Rev 7: 83-105.
46. Panda A, Qian F, Mohanty S, van Duin D, Newman FK, et al. (2010) Age-Associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol 184: 2518-2527. doi: 10.4049/jimmunol.0901022
47. Dresch C, Leverrier Y, Marvel J, Shortman K (2012) Development of antigen cross-presentation capacity in dendritic cells. Trends Immunol 33: 381-388. doi: 10.1016/j.it.2012.04.009
48. Dorrington MG, Bowdish DM (2013) Immunosenescence and novel vaccination strategies for the elderly. Front Immunol 4: 171. doi: 10.3389/fimmu.2013.00171
49. He XS, Holmes TH, Zhang C, Mahmood K, Kemble GW, et al. (2006) Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol 80: 11756-11766.
50. Thomas PG, Keating R, Hulse-Post DJ, Doherty PC (2006) Cell-mediated protection in influenza infection. Emerg Infect Dis 12: 48-54.
51. Koyama S, Ishii KJ, Kumar H, Tanimoto T, Coban C, et al. (2007) Differential role of TLR-And RLR-signaling in the immune responses to influenza A virus infection and vaccination. J Immunol 179: 4711-4720.
52. Budimir N, de Haan A, Meijerhof T, Waijer S, Boon L, et al. (2013) Critical role of TLR7 signaling in the priming of cross-protective cytotoxic T lymphocyte responses by a whole inactivated influenza virus vaccine. PLoS One 8: e63163. doi: 10.1371/journal.pone.0063163
53. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, et al. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
54. Karttunen J, Sanderson S, Shastri N (1992) Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc Natl Acad Sci U S A 89: 6020-6024.
55. Moron G, Rueda P, Casal I, Leclerc C (2002) CD8alpha-CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules. J Exp Med 195: 1233-1245.
56. Molinari P, Crespo MI, Gravisaco MJ, Taboga O, Moron G (2011) Baculovirus capsid display potentiates OVA cytotoxic and innate immune responses. PLoS One 6: e24108. doi: 10.1371/journal.pone. 0024108
57. Sanderson S, Shastri N (1994) LacZ inducible, antigen/MHC-specific T cell hybrids. Int Immunol 6: 369-376.
58. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-Time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.